FdaApplication
ANDA 209603
Identifiers
- fda_app_no: ANDA209603
Properties
| Property | Value |
|---|---|
| applicant_name | APPCO PHARMA LLC |
| application_type | ANDA |
| approval_date | 2018-06-20 |
Products (4)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| LABETALOL HYDROCHLORIDE | LABETALOL HYDROCHLORIDE | 200MG | TABLET;ORAL |
| LABETALOL HYDROCHLORIDE | LABETALOL HYDROCHLORIDE | 300MG | TABLET;ORAL |
| LABETALOL HYDROCHLORIDE | LABETALOL HYDROCHLORIDE | 100MG | TABLET;ORAL |
| LABETALOL HYDROCHLORIDE | LABETALOL HYDROCHLORIDE | 400MG | TABLET;ORAL |
4 products